HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mostafa Mostafazadeh Selected Research

Mostafa Mostafazadeh Research Topics

Disease

5Neoplasms (Cancer)
03/2024 - 09/2020
4Breast Neoplasms (Breast Cancer)
01/2023 - 09/2020
4Edema (Dropsy)
06/2022 - 02/2014
4Inflammation (Inflammations)
06/2022 - 02/2014
2Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 06/2022
2Wounds and Injuries (Trauma)
06/2022 - 09/2017
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2018 - 01/2018
1Adenocarcinoma
03/2024
1COVID-19
07/2023
1Triple Negative Breast Neoplasms
01/2023
1Colonic Neoplasms (Colon Cancer)
06/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Neoplasm Metastasis (Metastasis)
03/2021
1Congenital Abnormalities (Deformity)
09/2020
1Abdominal Obesity
07/2018
1Communicable Diseases (Infectious Diseases)
09/2014
1Hypertension (High Blood Pressure)
02/2014
1Renal Colic
02/2014
1Hyperglycemia
02/2014

Drug/Important Bio-Agent (IBA)

4Formaldehyde (Formol)FDA Link
06/2022 - 02/2014
4CarrageenanIBA
06/2022 - 02/2014
3thymoquinoneIBA
03/2024 - 03/2021
2Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2021
2AntioxidantsIBA
09/2020 - 09/2017
1Rhodamine 123IBA
03/2024
1LGK974IBA
03/2024
1Acetic Acid (Vinegar)FDA LinkGeneric
07/2023
1vandetanib (ZD6474)IBA
01/2023
1Protein-Arginine DeiminasesIBA
09/2022
1CateninsIBA
09/2022
1nitazoxanide (NTZ)FDA Link
09/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Interleukin-1 (Interleukin 1)IBA
10/2021
1cadherin 5IBA
03/2021
12,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA
09/2020
1CalciumIBA
09/2020
1benz(a)anthracene (benzanthracene)IBA
09/2020
1Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2020
1ResistinIBA
07/2018
1Blood Glucose (Blood Sugar)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Xylenes (Xylene)IBA
09/2014

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2022 - 01/2021
2Therapeutics
03/2021 - 01/2021
2Traditional Medicine (Folk Remedies)
09/2014 - 02/2014
1Topical Administration
09/2014